Gliomas Clinical Trials

A listing of Gliomas medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 111 clinical trials
Investigating Safety Tolerability Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours

A study to find out whether olaparib is safe and well tolerated when administered to children and adolescents with solid tumours

  • 03 Sep, 2021
  • 20 locations
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

This is a phase 1 study of an anti-CD40 monoclonal antibody (2141-V11) in combination with D2C7-IT for patients with recurrent World Health Organization (WHO) grade III or IV malignant glioma at

brain tumor
malignant glioma
recurrent malignant glioma
  • 31 Jul, 2021
  • 1 location
Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma

This is a Phase I study that examines the rate of dose limiting side effects in patients with malignant astrocytoma treated with combination acetazolamide (ACZ) and temozolomide (TMZ). Eligible patients must have histologically proven newly diagnosed, O6-methylguanine-DNA methyltransferase (MGMT) methylated WHO grade III or IV astrocytoma and be planning to …

  • 22 Jun, 2021
  • 1 location
DAY101 In Gliomas and Other Tumors

This research study is studying a drug DAY101 (formerly TAK-580, MLN2480) as a possible treatment a low-grade glioma that has not responded to other treatments. The name of the study drug

measurable disease
ejection fraction
  • 24 Sep, 2021
  • 15 locations
[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )

Subjects with histologically proven glioblastoma (GBM) who are suspected to have progression and are candidates for a surgical resection according to standard of care may be eligible for this study. Subjects may participate in this study if they are at least 18 years of age. Positron emission tomography (PET/CT) imaging …

karnofsky performance status
  • 25 Jul, 2021
  • 1 location
68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

This study will assess the potential of the 68Ga-NODAGA-RGD for the evaluation of neoangiogenesis in patients followed for a neoplastic pathology and for whom a18F-FDG (or 18F-FET for gliomas

  • 05 Aug, 2021
  • 1 location
A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations

An open label single-arm clinical trial to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of HMPL-306 in advanced or metastatic solid tumors with IDH mutation.

  • 03 Jun, 2021
  • 2 locations
Immunotherapy (Nivolumab and Ipilimumab) Before and After Surgery for the Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

This phase I trial studies the side effects of nivolumab and ipilimumab before and after surgery in treating children and young adults with high grade glioma that has come back (recurrent) or is

hematopoietic growth factors
growth factor
tumor progression
  • 12 Sep, 2021
  • 12 locations
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 Mutations

, including but not limited to cholangiocarcinoma, chondrosarcoma, and glioma.

measurable disease
systemic therapy
cancer chemotherapy
  • 18 Aug, 2021
  • 49 locations
Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma

This is a pilot study to assess a new methodology developed for High Grade Glioma (HGG). FMISO PET (Fluoromisonidazole-PET) allows researchers to study whether tumor cells lack oxygen (hypoxia

  • 15 Apr, 2021
  • 1 location